Methods for dosing an activin-ActRIIa antagonist and monitoring of treated patients

Details for Australian Patent Application No. 2009262970 (hide)

Owner Acceleron Pharma Inc.

Inventors Sherman, Matthew L.; Borgstein, Niels

Agent Shelston IP

Pub. Number AU-A-2009262970

PCT Pub. Number WO2009/158035

Priority 61/133,354 26.06.08 US

Filing date 26 June 2009

Wipo publication date 30 December 2009

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

G01N 33/20 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Metals

G01N 33/72 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving blood pigments, e.g. hemoglobin, bilirubin

Event Publications

3 February 2011 PCT application entered the National Phase

  PCT publication WO2009/158035 Priority application(s): WO2009/158035

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009262985-Fair resource sharing in wireless communications

2009262968-Antagonists of activin-ActRIIa and uses for increasing red blood cell levels